Literature DB >> 26336233

Potential for Psorophora columbiae and Psorophora ciliata Mosquitoes (Diptera: Culicidae) to Transmit Rift Valley Fever Virus.

Michael J Turell1, Seth C Britch2, Robert L Aldridge2, Rui-De Xue3, Mike L Smith3, Lee W Cohnstaedt4, Kenneth J Linthicum2.   

Abstract

Rift Valley fever virus (RVFV) continues to pose a threat to much of the world. Unlike many arboviruses, numerous mosquito species have been associated with RVFV in nature, and many species have been demonstrated as competent vectors in the laboratory. In this study, we evaluated two field-collected Psorophora species, Psorophora columbiae (Dyar and Knab) and Psorophora ciliata (F.) for their potential to transmit RVFV in North America. Both species were susceptible to infection after feeding on a hamster with a viremia of 10(7) plaque-forming units/ml, with infection rates of 65 and 83% for Ps. columbiae and Ps. ciliata, respectively (with nearly all specimens becoming infected when feeding on a hamster with a higher viremia). However, both species had a significant salivary gland barrier, as only 2/35 Ps. columbiae and 0/3 Ps. ciliata with a disseminated infection transmitted virus by bite. Despite the presence of the salivary gland barrier, due to the very high population that can occur and its propensity to feed on large mammals, Ps. columbiae might play a role in amplifying RVFV should that virus be introduced into an area where this species is common. Published by Oxford University Press on behalf of Entomological Society of America 2015. This work is written by US Government employees and is in the public domain in the US.

Entities:  

Keywords:  North America; competence; transmission; vector

Mesh:

Year:  2015        PMID: 26336233     DOI: 10.1093/jme/tjv093

Source DB:  PubMed          Journal:  J Med Entomol        ISSN: 0022-2585            Impact factor:   2.278


  5 in total

Review 1.  Molecular aspects of Rift Valley fever virus and the emergence of reassortants.

Authors:  Natasha N Gaudreault; Sabarish V Indran; Velmurugan Balaraman; William C Wilson; Juergen A Richt
Journal:  Virus Genes       Date:  2018-11-13       Impact factor: 2.332

Review 2.  Current Status of Rift Valley Fever Vaccine Development.

Authors:  Bonto Faburay; Angelle Desiree LaBeaud; D Scott McVey; William C Wilson; Juergen A Richt
Journal:  Vaccines (Basel)       Date:  2017-09-19

3.  RVFV Infection in Goats by Different Routes of Inoculation.

Authors:  Andrea L Kroeker; Valerie Smid; Carissa Embury-Hyatt; Estella Moffat; Brad Collignon; Oliver Lung; Robbin Lindsay; Hana Weingartl
Journal:  Viruses       Date:  2018-12-12       Impact factor: 5.048

4.  A Recombinant Rift Valley Fever Virus Glycoprotein Subunit Vaccine Confers Full Protection against Rift Valley Fever Challenge in Sheep.

Authors:  Bonto Faburay; William C Wilson; Natasha N Gaudreault; A Sally Davis; Vinay Shivanna; Bhupinder Bawa; Sun Young Sunwoo; Wenjun Ma; Barbara S Drolet; Igor Morozov; D Scott McVey; Juergen A Richt
Journal:  Sci Rep       Date:  2016-06-14       Impact factor: 4.379

5.  Biologically Informed Individual-Based Network Model for Rift Valley Fever in the US and Evaluation of Mitigation Strategies.

Authors:  Caterina M Scoglio; Claudio Bosca; Mahbubul H Riad; Faryad D Sahneh; Seth C Britch; Lee W Cohnstaedt; Kenneth J Linthicum
Journal:  PLoS One       Date:  2016-09-23       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.